ALPINE IMMUNE SCIENCES, INC. 3 SEC Filings

Filed On	Filing
05 Apr 2024	Form 3: Fuhs Ulrich Martin, Chief Accounting Officer Holds 7,300 shares of Common Stock
04 Oct 2023	Form 3: Dummer Wolfgang, Chief Medical Officer No securities owned
27 Apr 2023	Form 3: Durand Remy, Chief Business Officer Holds 6,904 shares of Common Stock
18 Aug 2022	Form 3: Sandler Andrew Seth, Chief Medical Officer No securities owned
19 Jul 2022	Form 3: Drappa Jorn, Director No securities owned
02 Jun 2021	Form 3: Goldberg Zelanna, Chief Medical Officer No securities owned
11 Dec 2020	Form 3: Hernday Natasha, Director No securities owned
23 Jan 2019	Form 3: Cui Xiangmin, Director No securities owned
23 Jan 2019	Form 3: Decheng Capital China Life Sciences Usd Fund III, L.p., 10% owner and 1 other Holds 3,165,735 shares of Common Stock
08 Aug 2018	Form 3: Litton Mark James, See Remarks No securities owned
24 Apr 2018	Form 3: Peetz Christopher, Director No securities owned
28 Jul 2017	Form 3: Frazier Life Sciences VIII, L.p., 10% owner and 3 others Holds 2,199,011 shares of Common Stock
26 Jul 2017	Form 3: Rickey James Paul, Senior VP and CFO No securities owned
26 Jul 2017	Form 3: Topper James N, Director No securities owned
26 Jul 2017	Form 3: Thompson Peter A., Director No securities owned
26 Jul 2017	Form 3: Orbimed Advisors Llc, Director and 2 others No securities owned
26 Jul 2017	Form 3: Peng Stanford L, See Remarks No securities owned
26 Jul 2017	Form 3: Venkatesan Jay, Director No securities owned
26 Jul 2017	Form 3: Gold Mitchell, Director No securities owned
26 Jul 2017	Form 3: Alpine ImmunoSciences, L.p., 10% owner and 1 other Holds 3,803,906 shares of Common Stock

Comments